If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

  • This share is currently suspended. It was suspended at a price of 0.306
  • There is currently no data for BMN

Result of General Meeting

27 Dec 2023 14:30

RNS Number : 9660X
Bushveld Minerals Limited
27 December 2023

Market Abuse Regulation ("MAR") Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

27 December 2023

Bushveld Minerals Limited

("Bushveld" or the "Company")

General Meeting Results

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that all ordinary and special resolutions put to shareholders at the General Meeting held earlier today were duly passed.

No.

Ordinary Resolution

Votes

In Favour

Against

Withheld

1

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion in accordance with Article 8.3 of the Articles ("Resolution 1" of the circular)

779,492,174

11,854,933

927,811

2

To provide the flexibility to the Directors to issue shares from time to time and grant the authority until the next annual general meeting (unless such authority is revoked or renewed prior to such time) by authorising the Directors in accordance with Article 8.3 of the Articles to issue relevant securities up to an aggregate nominal amount equal to approximately one third of the Enlarged Share Capital ("Resolution 3" of the circular).

775,167,570

16,178,973

928,375

Special Resolution

3

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion as if the pre-emption rights contained in Article 9.2 of the Articles did not apply to such issue ("Resolution 2" of the circular).

777,189,029

13,283,193

1,802,696

4

To disapply the pre-emption rights contained in Article 9.9 of the Articles in respect of the issuance of equity securities for cash pursuant to rights issues and other pre-emptive issues, and in respect of other issues of equity securities for cash up to an aggregate nominal value which equates to approximately 10 per cent of the Enlarged Share Capital ("Resolution 4" of the circular).

777,440,625

13,253,943

1,580,350

Admission, Settlement and Total Voting Rights

An application has been made to the London Stock Exchange for the 395,897,277 Fundraise Shares and 124,267,747 Orion Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the Fundraise Shares and Orion Shares to be issued pursuant to the Fundraise will commence on or around 28 December 2023.

Following Admission, there will be a total of 2,311,213,138 Ordinary Shares in issue, 670,000 of which are held in treasury. Shareholders should use the figure of 2,310,543,138 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure and Transparency Rules.

The new Ordinary Shares to be issued pursuant to the PrimaryBid Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the new Ordinary Shares to be issued pursuant to the Placing, the Subscription and the Company's existing Ordinary Shares.

Furthermore, as announced on 5 December 2023, Acacia Resources Limited subscribed for 92,592,592 new ordinary shares of 1 pence each in the Company, which will be settled on or before 28 February 2024. A separate AIM application and announcement will be made regarding the admission of these shares to trading on AIM.

Craig Coltman, CEO of Bushveld Minerals Limited, commented:

"I would like to thank the shareholders for voting in favour of all the resolutions. Your support is of utmost importance as the equity raise which will provide the necessary resources for the Company to meet its financial obligations, increase production and ensure stability."

Enquiries: info@Bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser, Joint Broker & Joint Bookrunner

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

Grant Barker / Richard Parlons

Hannam & Partners

Joint Broker & Joint Bookrunner

+44 (0) 20 7907 8500

Andrew Chubb / Matt Hasson / Jay Ashfield

Tavistock

Financial PR

+44 (0) 207 920 3150

Gareth Tredway / Tara Vivian-Neal / James Whitaker

ENDS

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ROMXDLFLXLLZFBE
Date   Source Headline
16th May 20257:00 amRNSCancellation - Bushveld Minerals Limited
15th Apr 20254:28 pmRNSAppointment of Liquidators & Resignation of Nomad
11th Apr 20257:57 amRNSNotice of appointment of liquidators
15th Jan 20256:00 pmRNSBushveld Minerals
16th Dec 20247:15 amRNSBusiness Rescue and Operations Update
4th Dec 20247:00 amRNSResignation of Directors
29th Nov 20247:00 amRNSDefault on Shareholder Loan Repayment by Vanchem
19th Nov 202410:01 amRNSAppointment of Business Rescue Practitioners
18th Nov 20247:30 amRNSSuspension - Bushveld Minerals Limited
18th Nov 20247:00 amRNSTrading Suspension
8th Nov 20249:25 amRNSQ3 and 9M 2024 Operational Update
1st Nov 20243:05 pmRNSVanchem Sale Update
25th Oct 20242:21 pmRNSOperational Update
18th Oct 20249:18 amRNSDisposal of Interests in Lemur Holdings Limited
17th Sep 20247:00 amRNSInterim Results for Six Months ended 30 June 2024
10th Sep 20247:00 amRNSTurnaround Initiatives Underway
2nd Sep 20244:22 pmRNSOrion Matched Funding Received
14th Aug 20246:00 pmRNSSARB Approval for Orion US$10M Matched Funding
12th Aug 20244:13 pmRNSUS$2 million SPR Debt Funding Received
9th Aug 20249:55 amRNSAgreement re Settlement of SPR Subscription Funds
7th Aug 20244:25 pmRNSAnnual General Meeting Results
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSAnnual General Meeting Statement
31st Jul 20247:00 amRNSQ2 and H1 2024 Operational Update
24th Jul 20244:46 pmRNSHolding(s) in Company - Correction
15th Jul 202412:39 pmRNSDirector/PDMR Shareholding
12th Jul 20244:57 pmRNSDirector/PDMR Shareholding
11th Jul 20245:04 pmRNSPosting of Accounts & Notice of General Meeting
28th Jun 20245:30 pmRNSFinal Results for Year Ended 31 December 2023
28th Jun 20243:29 pmRNSFinancing Update: Orion matched funding of US$10m
28th Jun 20241:17 pmRNSHolding(s) in Company
26th Jun 202412:13 pmRNSHolding(s) in Company
24th Jun 20241:50 pmRNSSPR Funding & Orion 2024 Financing Package Update
31st May 20244:07 pmRNSCCSA Approval for sale of 64% interest in Mokopane
31st May 20241:07 pmRNSResult of Meeting
24th May 20245:53 pmRNSShareholder Correspondence and Questions & Answers
13th May 20247:00 amRNSPosting of Circular and Notice of General Meeting
7th May 20247:00 amRNSProposed conditional disposal of Vanchem
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.